A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
UPMC Hillman Cancer Center provides the finest level of cancer care to patients throughout the tristate (Pennsylvania, Ohio, West Virginia) region. We offer patients the latest advances in cancer prevention, detection, diagnosis, and treatment.
Pittsburgh, Pennsylvania Clinical Trial Location
UPMC Hillman Cancer Center
5115 Centre Ave,
Pittsburgh, PA 15232